KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Debt to Equity (2018 - 2025)

Twist Bioscience (TWST) has disclosed Debt to Equity for 4 consecutive years, with $0.01 as the latest value for Q4 2021.

  • On a quarterly basis, Debt to Equity rose 133.77% to $0.01 in Q4 2021 year-over-year; TTM through Dec 2021 was $0.01, a 133.77% increase, with the full-year FY2021 number at $0.0, down 81.03% from a year prior.
  • Debt to Equity was $0.01 for Q4 2021 at Twist Bioscience, up from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.08 in Q1 2019 to a low of -$0.05 in Q3 2018.
  • A 4-year average of $0.03 and a median of $0.02 in 2020 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: surged 205.39% in 2019, then tumbled 90.87% in 2020.
  • Twist Bioscience's Debt to Equity stood at $0.07 in 2018, then dropped by 4.51% to $0.07 in 2019, then crashed by 90.87% to $0.01 in 2020, then soared by 133.77% to $0.01 in 2021.
  • Per Business Quant, the three most recent readings for TWST's Debt to Equity are $0.01 (Q4 2021), $0.0 (Q3 2021), and $0.0 (Q2 2021).